Evolus Share Price Today
(NASDAQ: EOLS)

Name: Evolus Share Price Today (NASDAQ: EOLS) - Evolus Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Evolus share price is $13.28 & ₹1,149.65 as on 19 Mar 2025, 2.30 'hrs' IST

$13.28

▲

-0.31

(-2.28%)

Market is closed - opens 7 PM, 19 Mar 2025

View live Evolus share price in Dollar and Rupees. Guide to invest in Evolus stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Evolus, along with analyst recommendations, forecasts, and comprehensive financials.

Evolus share price movements

Today's Low: $13.07
Today's High: $13.43
$13.28
1.58%
Downside
Day's Volatility :2.64%
Upside
1.08%
52 Weeks Low: $9.25
52 Weeks High: $17.82
$13.28
30.35%
Downside
52 Weeks Volatility :48.09%
Upside
25.48%

Evolus (EOLS) Returns

Period	Evolus, Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	19.86%	7.7%	0.0%
6 Months	-18.13%	-5.8%	0.0%
1 Year	-5.01%	0.7%	0.0%
3 Years	20.95%	7.2%	-15.2%

Evolus (EOLS) Key Statistics

in dollars & INR

Previous Close	$13.59
Open	$13.38
Today's High	$13.425
Today's Low	$13.07
Market Capitalization	$844.4M
Today's Volume	$725.8K
52 Week High	$17.82
52 Week Low	$9.25
Revenue TTM	$266.3M
EBITDA	$-21.9M
Earnings Per Share (EPS)	$-0.81
Profit Margin	-18.94%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-861.68%

How to invest in Evolus Stock (EOLS) from India?

It is very easy for Indian residents to invest directly in Evolus from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Evolus stock in both Indian Rupees (INR) and US Dollars (USD). Search for Evolus or EOLS on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Evolus or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Evolus shares which would translate to 0.065 fractional shares of Evolus as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Evolus, in just a few clicks!

Returns in Evolus (EOLS) for Indian investors in Rupees

The Evolus stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Evolus investment value today

Current value as on today

₹99,319

Returns

₹681

(-0.68%)

Returns from Evolus Stock

₹5,007 (-5.01%)

Dollar Returns

₹4,326 (+4.33%)

Indian investors sentiment towards Evolus (EOLS)

18%

Period: Feb 16, 2025 to Mar 18, 2025. Change in 30 Days versus previous period

Search interest for Evolus Stock from India on INDmoney has increased by 18% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Evolus

Walleye Trading Advisors, LLC
0.43%

Analyst Recommendation on Evolus

Buy

92%Buy

7%Hold

0%Sell

Based on 14 Wall street analysts offering stock ratings for Evolus(by analysts ranked 0 to 5 stars)

Based on 14 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Evolus Stock (EOLS)

What analysts predicted

Upside of 81.8%

Target:

$24.14

Current:

$13.28

Insights on Evolus Stock (Ticker Symbol: EOLS)

Price Movement
In the last 3 months, EOLS stock has moved up by 22.2%
Increasing Revenue
Revenue is up for the last 2 quarters, 61.08M → 78.94M (in $), with an average increase of 22.6% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -19.17M → -6.79M (in $), with an average increase of 182.3% per quarter
EOLS vs ITCI (1 yr)
In the last 1 year, Intra-cellular Therapies, Inc. has given 100.8% return, outperforming this stock by 105.8%
EOLS vs ITCI (3 yr)
In the last 3 years, Intra-cellular Therapies, Inc. has given 115.3% return, outperforming this stock by 98.7%
Price to Sales
ForEOLS every $1 of sales, investors are willing to pay $3.1, whereas for Intra-cellular Therapies, Inc., the investors are paying $19.9 for every $1 of sales.

Evolus Technicals Summary

Sell

Neutral

Buy

Evolus is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Evolus (EOLS) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Evolus, Inc.	-10.21%	-18.13%	-5.01%	20.95%	265.84%
Intra-cellular Therapies, Inc.	2.73%	75.97%	100.84%	124.24%	872.26%
Haleon Plc Spon Ads	3.0%	-2.46%	22.79%	38.87%	38.87%
Zoetis Inc.	5.08%	-16.31%	-4.93%	-15.55%	62.9%
Viatris Inc.	-12.34%	-20.0%	-19.8%	-11.61%	-41.74%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Evolus, Inc.	NA	NA	NA	-0.01	-8.62	-0.08	NA	0.09
Intra-cellular Therapies, Inc.	NA	NA	0.0	0.13	-0.09	-0.07	NA	10.81
Haleon Plc Spon Ads	25.1	25.1	1.81	0.32	0.09	0.04	0.02	1.8
Zoetis Inc.	30.01	30.01	2.92	6.07	0.51	0.15	0.01	10.64
Viatris Inc.	224.4	NA	0.16	2.2	-0.03	0.02	0.05	15.61

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Evolus, Inc.	Buy	$844.4M	265.84%	NA	-18.94%
Intra-cellular Therapies, Inc.	Buy	$14.0B	872.26%	NA	-10.97%
Haleon Plc Spon Ads	Buy	$46.5B	38.87%	25.1	12.84%
Zoetis Inc.	Buy	$73.6B	62.9%	30.01	26.86%
Viatris Inc.	Hold	$11.0B	-41.74%	224.4	-4.3%

About Evolus

Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels. The company was incorporated in 2012 and is headquartered in Newport Beach, California.

Organization	Evolus
Employees	332
CEO	Mr. David Moatazedi
Industry	Health Technology

Management People of Evolus

Name	Title
Mr. David Moatazedi	President, CEO & Director
Ms. Sandra Beaver	Chief Financial Officer
Dr. Rui Avelar C.CFP, Dip.SportMed, M.D.	Chief Medical Officer and Head of Research & Development
Mr. Nareg Sagherian	Head of Global Investor Relations & Corporate Communications
Mr. Jeffrey J. Plumer	General Counsel
Mr. Kurt Knab	Senior Vice President of Sales
Ms. Tomoko Yamagishi-Dressler	Chief Marketing Officer
Ms. Jessica Novak	Senior Vice President of Human Resources

Important FAQs about investing in EOLS Stock from India :

What is Evolus share price today?

Evolus share price today stands at $13.28, Open: $13.38 ; Previous Close: $13.59 ; High: $13.43 ; Low: $13.07 ; 52 Week High: $17.82 ; 52 Week Low: $9.25.

The stock opens at $13.38, after a previous close of $13.59. The stock reached a daily high of $13.43 and a low of $13.07, with a 52-week high of $17.82 and a 52-week low of $9.25.

Can Indians buy Evolus shares?

Yes, Indians can invest in the Evolus (EOLS) from India.

With INDmoney, you can buy Evolus at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Evolus at zero transaction cost.

How can I buy Evolus shares from India?

It is very easy to buy Evolus from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Evolus (EOLS) be purchased?

Yes, you can buy fractional shares of Evolus with INDmoney app.

What are the documents required to start investing in Evolus stocks?

To start investing in Evolus, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.